Received: 13 July 2020
Accepted: 27 November 2020
First Online: 14 January 2021
Ethics approval and consent to participate
: This study was performed in accordance with the Declaration of Helsinki and complied with the regulations of the Institutional Review Boards of the medical universities. Ethics committee approval was sought before commencement of triheptanoin in the compassionate use program. Written consent was obtained from all study participants.
: Written consent was obtained.
: The authors declare that they have no competing interests.